Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07536841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

Study acronym: ОС26
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Primary completion moved earlier from Oct 1, 2026 to May 1, 2026
    • Study completion moved earlier from Dec 31, 2026 to Dec 1, 2026
    • Site details revised at 2 of 2 sites
    v3
  2. Primary endpoint(s) modifiedv2 Show 5 more changesShow less
    • Study sites: 0 to 2
    • Interventions: No intervention (observational study) (Other)
    • Secondary endpoints expanded, about 26 words
    • Study description shortened, about 109 words
    • Study title shortened, about 8 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.
Trial Details
NCT Number NCT07536841
Lead Sponsor Military Medical Clinical Center of the Southern Region, Ukraine
Conditions
(from sponsor)		 Autoimmune Pancreatitis, IgG4-Related Diseases, Pancreatic Cancer, Chronic Pancreatitis
Related terms Autoimmune Pancreatitis, Immunoglobulin G4-Related Disease, Pancreatic Neoplasms, Pancreatitis, Chronic
Enrollment 82 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov